Kurt von Emster
Signal active
Managing Partner
Bio
N/A
Location
London, England, United Kingdom, Europe
Social
Primary Organization
Abingworth
Founded
1973
Investment
181
Lead investment
52
Exits
84
Employees
11-50
Industry
Biotechnology, Medical, Medical Device, Health Diagnostics
Jobs history
10
Iambic Therapeutics
Board Member
Invalid date - Current
SFJ Pharmaceuticals
Board Member
2020 - Current
Vaxcyte
Board Member
2015 - Current
Orbus Therapeutics
Board Member
2020 - Current
Trishula Therapeutics
Board Member
2020 - Current
CymaBay Therapeutics
Board of Directors
2009 - Current
Jasper Therapeutics
Board Member
2019 - Current
Vera Therapeutics
Board Member
2020 - Current
CRISPR Therapeutics
Member Board of Directors
2015 - 2019
Tizona Therapeutics
Board Member
2020 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Kurt von Emster is the Managing Partner at Abingworth, based in Europe. With a background in Biotechnology, Kurt von Emster has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
7
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Jan 19, 2021 | Vera Therapeutics | Series C - Vera Therapeutics | Abingworth | 80.0M |
| Apr 11, 2022 | Launch Therapeutics | Private Equity Round - Launch Therapeutics | Abingworth | 0 |
| Oct 03, 2023 | Iambic Therapeutics | Series B - Iambic Therapeutics | Abingworth | 100.0M |
| Apr 24, 2024 | Iambic Therapeutics | Series B - Iambic Therapeutics | Abingworth | 50.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.